Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M)...

Related Keywords

New York ,United States ,Mumbai ,Maharashtra ,India ,Hong Kong ,United Kingdom ,Singapore ,Ahmedabad ,Gujarat ,Riverview ,London ,City Of ,Nandini Piramal ,Contract Development ,Hemmo Pharmaceuticals Pvt Ltd ,Twitter ,Piramal Pharma Ltd ,Prnewswire Piramal Pharma Limited ,Carlyle Group ,Manufacturing Organization ,Piramal Pharma Solutions ,Allergan ,Facebook ,Convergence Chemical Pvt Ltd ,Piramal Pharma ,Piramal Pharma Limited ,Vitro Lab ,Piramal Enterprises Ltd ,Pharma Limited ,Complex Hospital Generic ,Inhalation Anesthesia ,India Consumer Healthcare ,Business Highlights ,In Vitro Lab ,Hospital Generics ,Pain Management ,Consumer Healthcare ,Lacto Calamine ,Voluntary Action ,Forwarding Agent ,Primary Number ,Eastern Time ,London Time ,Singapore Time ,Hong Kong Time ,Diamond Pass ,Piramal Critical Care ,Complex Hospital Generics ,